Illumina Nets $340M in Public Offering | GenomeWeb
NEW YORK (GenomeWeb News) – Illumina said today that it has raised net proceeds of $342.6 million in a public stock offering.
The company said that it sold 4,025,000 shares at $87.50 per share in the offering.
Goldman, Sachs was the sole manager of the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.